LORELEI OPENE: Open Payments
NPI 1659350445 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 23 payments from 9 companies in 2025. Trend: 2023 $140 · 2024 $269 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $163 |
| PFIZER INC. | 5 | $138 |
| Janssen Biotech, Inc. | 3 | $78 |
| ABBVIE INC. | 3 | $69 |
| Phathom Pharmaceuticals, Inc. | 2 | $67 |
| Ardelyx, Inc. | 2 | $52 |
| Braintree Laboratories, Inc. | 1 | $34 |
| Novo Nordisk Inc | 1 | $24 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
Products named: DUPIXENT, VELSIPITY, TREMFYA, VOQUEZNA, IBSRELA, CREON, SUFLAVE, Wegovy.
Industry payments across CA — which companies pay providers there.
